Arkolith/Insider Trading/HCWB/Form 4

Byam Rebecca

Chief Financial OfficerHCW Biologics Inc. (HCWB) · full profile →Form 4 · filed Aug 26, 2022
Net Buying
Open-Market Buys
$229K
Open-Market Sells
$0
Net Open-Market Flow
$229K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2022Buy(P)40K$2.59$104K246K
Aug 24, 2022Buy(P)50K$2.50$125K205K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-047721) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML